New standards may help push more drugmakers to use a synthetic product for critical drug safety testing, instead of one made from horseshoe crab blood that has long drawn criticism. The U.S.
Morning Overview on MSN
Drugmakers shift from horseshoe crab blood tests to synthetic options
The U.S. Pharmacopeia has approved synthetic alternatives to horseshoe crab blood for bacterial endotoxin testing, a regulatory shift that could reduce the pharmaceutical industry’s reliance on ...
In this episode of C&EN Uncovered, host Craig Bettenhausen speaks with C&EN assistant editor Laurel Oldach about the use of horseshoe crab blood in pharmaceutical endotoxin testing, the challenges of ...
Animal rights groups have been pushing a synthetic alternative to horseshoe crab blood in drug safety testing Horseshoe crabs’ icy-blue blood will remain the drug industry’s standard for safety tests ...
This article discusses current methods of endotoxin testing, its importance to the industry, sustainability issues relating to the process, and best practices. The potentially devastating effects of ...
In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, vice president, Technical at Parexel, discuss ...
DOVER, DE, UNITED STATES, January 21, 2026 /EINPresswire.com/ — The global pharmaceutical supply chain is currently confronting a dual imperative: ensuring ...
Lonza has announced an expansion to its PyroTec® PRO Automated Robotic Solution for endotoxin testing. The new PyroWave® Reader add-on has been designed specifically for use with the sustainable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results